Notice Number: NOT-DA-13-002

Updates: The following updates relating to this announcement have been issued:

• January 24, 2014 - See Notice NOT-DA-14-004, which replaces this Notice to update the catalog of research cigarettes and ordering guidelines from the NIDA Drug Supply Program.

Key Dates
Release Date: October 5, 2012

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

This Notice communicates the availability and procedures for acquisition of nicotine research cigarettes (NRC) through the NIDA Drug Supply Program (DSP). Information provided in this Notice will help the NIDA DSP and investigators effectively plan for the use of NRC and for responses to Funding Opportunity Announcements.

The NIDA DSP facilitates investigators' research by providing chemicals, including some chemicals needed for tobacco-related research, as well as research probes that are either unavailable, difficult to obtain, or very expensive for researchers to buy. Additionally, this program provides analytical services for analyses of researchers' experimental samples. Guidelines for U.S. research investigators to order from the DSP can be found here: http://www.drugabuse.gov/sites/default/files/files/OrderingGuidelinesUS.pdf.

Limited quantities of nicotine research cigarettes (NRC) manufactured through NIDA DSP are available to the research community under specified parameters for content of nicotine, menthol, and tar. The NIDA DSP will consider requests for its current inventory of NRC from researchers funded through the NIH to conduct tobacco science research. When needs are outside of the current inventory, additional NRC may be manufactured and made available to approved researchers if funds become available. To facilitate planning for either usage of the current inventory of NRC, or future manufacturing needs, the NIDA DSP requests that researchers requiring the use of NRC who may need NRC from NIDA DSP send an email request with the following information: 1) anticipated total number of each type of NRC needed, 2) the requested timeline and amounts for initial receipt, and 3) requested timeline of replenishment of each type of NRC.

Characteristics of the NRC inventory are described in the following table:

Inquiries

Please direct DSP and NRC inquiries to:

Hari H. Singh, Ph.D.
Program Director
Drug Supply & Analytical Services
Chemistry & Physiological Systems Research Branch
Division of Basic Neuroscience & Behavioral Research
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard, Room # 4282, MSC 9555
Bethesda, MD 20892-9555
Phone: (301) 435-1310
Fax: (301) 594-6943
E-mail: hsingh1@nida.nih.gov

Please direct other program inquiries related to Funding Opportunity Announcements (FOAs) through NIH or the NIH-FDA interagency partnership to the points of contact listed within the FOA.